Adam Leach

Adam Leach is a Senior Scientist at Nuntius Therapeutics since May 2022, focusing on the delivery of therapeutic macromolecules in cancer treatment. Previously, Adam served as a Postdoctoral Fellow at The Institute of Cancer Research, where work involved the engineering of protein therapeutics against SARS-CoV-2. Adam's academic background includes a PhD from Queen's University Belfast, with research centered on polymeric nanoparticles for pancreatic cancer, as well as a BA and MSci in Natural Sciences from the University of Cambridge.